|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 08, 2021 |
Title |
HCC827 GSK-J4 rep1 |
Sample type |
SRA |
|
|
Source name |
HCC827
|
Organism |
Homo sapiens |
Characteristics |
cell type: Lung adenocarcinoma agent: GSK-J4 cell line: HCC827
|
Treatment protocol |
DMSO or 10 µM of GSK-J4 is treated for 24h.
|
Growth protocol |
HCC827, H23 and A549 were cultured in DMEM (Welgene, Republic of Korea) supplemented with 10% fetal bovine serum (Welgene, Republic of Korea).
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNAs were isolated using RNeasy mini kits (Qiagen, Valencia, CA). The Libraries were prepared using the TruSeq stranded mRNA sample preparation kit (Illumina).
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
HCC827 GSK-J4 rep1
|
Data processing |
Raw reads were mapped to the reference human (hg19) genome assembly with Tophat, and rpkm values were calculated with Cufflink Genome_build: Hg19 Supplementary_files_format_and_content: RPKM
|
|
|
Submission date |
Aug 08, 2018 |
Last update date |
Aug 08, 2021 |
Contact name |
Mi Young Kim |
E-mail(s) |
miyoungkim@kaist.ac.kr
|
Organization name |
KAIST
|
Street address |
Biological science
|
City |
DaeJeon |
ZIP/Postal code |
305-701 |
Country |
South Korea |
|
|
Platform ID |
GPL18573 |
Series (2) |
GSE118319 |
Genome-wide RNA-seq from GSK-J4-treated lung adenocarcinoma cell lines |
GSE133970 |
Genome-wide assessment of GSK-J4-treated lung adenocarcinoma cell lines |
|
Relations |
BioSample |
SAMN09784713 |
SRA |
SRX4521969 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|